| Pharmaceutical active ingredients: |
| Flunisolide |
| Available forms, composition and doses of Nasalide: |
| Spray, Metered-Dose; Nasal; Flunisolide 0.025 mg / dose |
| Nasalide medical category: |
| Human:Anti-inflammatory agentsCorticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AD04 - FlunisolideR03BA03 - Flunisolide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| TevaIVAX |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nasaleze | Cellulose | DDD |
| Nasalflu | Influenza Vaccine | Berna |
| Nasalgen Syrup | Carbinoxamine Maleate; Phenylpropanolamine Hydrochloride | Kenyaku; Asian TJD Enterprise; Schumit 1967 |
| Nasalgen Tablets | Carbinoxamine Maleate; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Kenyaku; Asian TJD Enterprise; Schumit 1967 |
| Nasalgon | Echinacea Angustifolia; Ephedrine Hydrochloride; Hydroxyquinoline; Terpin Hydrate | Labopharma |
| Nasaliv | Acetaminophen; Carbinoxamine Maleate; Phenylephrine | Uniao Quimica Farmaceutica Nacional |
| Nasalt | Sodium Chloride | Greenco Biologicals |
| Nasaltex | Oxymetazoline Hydrochloride | Bristol-Myers Squibb |
| Nasalub | Glycerol; Sodium Chloride | Quimica y Farmacia |
| Nasamine | Dexchlorpheniramine Maleate | Maxi Medical Drug |